Pędzińska-Betiuk A - Search Results

1

Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes.

Dobrzyńska I, Szachowicz-Petelska B, Pędzińska-Betiuk A, Figaszewski ZA, Skrzydlewska E. Dobrzyńska I, et al. Among authors: pedzinska betiuk a. Toxicol Mech Methods. 2020 May;30(4):297-305. doi: 10.1080/15376516.2020.1727595. Epub 2020 Feb 20. Toxicol Mech Methods. 2020. PMID: 32028814

2

Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.

Toczek M, Baranowska-Kuczko M, Grzęda E, Pędzińska-Betiuk A, Weresa J, Malinowska B. Toczek M, et al. Pharmacol Rep. 2016 Apr;68(2):363-9. doi: 10.1016/j.pharep.2015.10.004. Epub 2015 Oct 24. Pharmacol Rep. 2016. PMID: 26922540

3

Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.

Pędzińska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B. Pędzińska-Betiuk A, et al. Br J Pharmacol. 2017 Jul;174(13):2114-2129. doi: 10.1111/bph.13830. Epub 2017 May 31. Br J Pharmacol. 2017. PMID: 28437860 Free PMC article.

4

The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.

Polak A, Harasim-Symbor E, Malinowska B, Kasacka I, Pędzińska-Betiuk A, Weresa J, Chabowski A. Polak A, et al. Life Sci. 2017 Aug 15;183:1-10. doi: 10.1016/j.lfs.2017.06.019. Epub 2017 Jun 17. Life Sci. 2017. PMID: 28633967

5

Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats.

Harasim-Symbor E, Polak A, Pędzińska-Betiuk A, Weresa J, Malinowska B, Lewandowska A, Kasacka I, Chabowski A. Harasim-Symbor E, et al. Among authors: pedzinska betiuk a. Chem Phys Lipids. 2019 Jan;218:141-148. doi: 10.1016/j.chemphyslip.2018.12.007. Epub 2018 Dec 19. Chem Phys Lipids. 2019. PMID: 30578756

6

Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism.

Remiszewski P, Jarocka-Karpowicz I, Biernacki M, Jastrząb A, Schlicker E, Toczek M, Harasim-Symbor E, Pędzińska-Betiuk A, Malinowska B. Remiszewski P, et al. Among authors: pedzinska betiuk a. Int J Mol Sci. 2020 Feb 14;21(4):1295. doi: 10.3390/ijms21041295. Int J Mol Sci. 2020. PMID: 32075117 Free PMC article.

7

Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart.

Pędzińska-Betiuk A, Weresa J, Schlicker E, Harasim-Symbor E, Toczek M, Kasacka I, Gajo B, Malinowska B. Pędzińska-Betiuk A, et al. Toxicol Appl Pharmacol. 2021 Jan 15;411:115368. doi: 10.1016/j.taap.2020.115368. Epub 2020 Dec 16. Toxicol Appl Pharmacol. 2021. PMID: 33338514 Free article.

8

Evaluation of the Expression and Localization of the Multifunctional Protein CacyBP/SIP and Elements of the MAPK Signaling Pathway in the Adrenal Glands of Rats with Primary and Secondary Hypertension.

Smereczańska M, Domian N, Młynarczyk M, Pędzińska-Betiuk A, Kasacka I. Smereczańska M, et al. Among authors: pedzinska betiuk a. Int J Mol Sci. 2023 Dec 20;25(1):84. doi: 10.3390/ijms25010084. Int J Mol Sci. 2023. PMID: 38203261 Free PMC article.

9

Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance.

Malinowska B, Toczek M, Pędzińska-Betiuk A, Schlicker E. Malinowska B, et al. Br J Pharmacol. 2019 May;176(10):1395-1411. doi: 10.1111/bph.14168. Epub 2018 Apr 14. Br J Pharmacol. 2019. PMID: 29455452 Free PMC article. Review.

10

Beneficial and harmful effects of CB₁ and CB₂ receptor antagonists on chronotropic and inotropic effects related to atrial β-adrenoceptor activation in humans and in rats with primary hypertension.

Weresa J, Pędzińska-Betiuk A, Schlicker E, Hirnle G, Mitrosz M, Malinowska B. Weresa J, et al. Among authors: pedzinska betiuk a. Clin Exp Pharmacol Physiol. 2021 Nov;48(11):1547-1557. doi: 10.1111/1440-1681.13560. Epub 2021 Aug 15. Clin Exp Pharmacol Physiol. 2021. PMID: 34333780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page